APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ulcerative Colitis Medicine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ulcerative Colitis Medicine Industry Growth and Trends Forecast to 2032

4 January 2026102 pages

Choose your research edition.

Industry ResearchUlcerative Colitis Medicine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Ulcerative Colitis Medicine Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Ulcerative Colitis Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ulcerative Colitis Medicine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Ulcerative Colitis Medicine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

According to APO Research, the global Ulcerative Colitis Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ulcerative Colitis Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ulcerative Colitis Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ulcerative Colitis Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Ulcerative Colitis Medicine market include Sumitomo, Pfizer, Novartis, Merck, Sanofi, Johnson and Johnson, GSK, AstraZeneca and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ulcerative Colitis Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ulcerative Colitis Medicine market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ulcerative Colitis Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ulcerative Colitis Medicine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Ulcerative Colitis Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ulcerative Colitis Medicine Market by Company

Sumitomo

Pfizer

Novartis

Merck

Sanofi

Johnson and Johnson

GSK

AstraZeneca

Cipla

Sun Pharm

Allergan

Teva Pharmaceutical

Ulcerative Colitis Medicine Segment by Type

5-Aminosalicylic Acid

Corticosteroids

Immunomodulator Drugs

Biologics

Ulcerative Colitis Medicine Segment by Application

Ulcerative Proctitis

Proctosigmoiditis

Left-Sided Colitis

Pancolitis

Acute Severe Ulcerative Colitis

Ulcerative Colitis Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ulcerative Colitis Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ulcerative Colitis Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ulcerative Colitis Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Ulcerative Colitis Medicine companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Ulcerative Colitis Medicine Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Ulcerative Colitis Medicine Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Ulcerative Colitis Medicine Market Share by Region (2021-2026) Table 4. Global Ulcerative Colitis Medicine Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Ulcerative Colitis Medicine Market Share by Region (2027-2032) Table 6. Global Ulcerative Colitis Medicine Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Ulcerative Colitis Medicine Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Ulcerative Colitis Medicine Market Size Share by Type (2021-2026) Table 9. Global Ulcerative Colitis Medicine Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Ulcerative Colitis Medicine Market Size Share Forecasted by Type (2027-2032) Table 11. North America Ulcerative Colitis Medicine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Ulcerative Colitis Medicine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Ulcerative Colitis Medicine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Ulcerative Colitis Medicine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Ulcerative Colitis Medicine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Ulcerative Colitis Medicine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Ulcerative Colitis Medicine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Ulcerative Colitis Medicine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Ulcerative Colitis Medicine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Ulcerative Colitis Medicine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Ulcerative Colitis Medicine Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Ulcerative Colitis Medicine Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Ulcerative Colitis Medicine Market Size Share by Application (2021-2026) Table 24. Global Ulcerative Colitis Medicine Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Ulcerative Colitis Medicine Market Size Share Forecasted by Application (2027-2032) Table 26. North America Ulcerative Colitis Medicine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Ulcerative Colitis Medicine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Ulcerative Colitis Medicine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Ulcerative Colitis Medicine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Ulcerative Colitis Medicine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Ulcerative Colitis Medicine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Ulcerative Colitis Medicine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Ulcerative Colitis Medicine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Ulcerative Colitis Medicine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Ulcerative Colitis Medicine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Ulcerative Colitis Medicine Industry Trends Table 37. Ulcerative Colitis Medicine Industry Drivers Table 38. Ulcerative Colitis Medicine Industry Opportunities and Challenges Table 39. Ulcerative Colitis Medicine Industry Restraints Table 40. Global Ulcerative Colitis Medicine Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Ulcerative Colitis Medicine Revenue Market Share by Company (2021-2026) Table 42. Global Ulcerative Colitis Medicine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Ulcerative Colitis Medicine Key Company Headquarters & Area Served Table 44. Global Ulcerative Colitis Medicine Company, Product Type & Application Table 45. Global Ulcerative Colitis Medicine Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Ulcerative Colitis Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Sumitomo Company Information Table 49. Sumitomo Business Overview Table 50. Sumitomo Ulcerative Colitis Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Sumitomo Ulcerative Colitis Medicine Product Portfolio Table 52. Sumitomo Recent Development Table 53. Pfizer Company Information Table 54. Pfizer Business Overview Table 55. Pfizer Ulcerative Colitis Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Pfizer Ulcerative Colitis Medicine Product Portfolio Table 57. Pfizer Recent Development Table 58. Novartis Company Information Table 59. Novartis Business Overview Table 60. Novartis Ulcerative Colitis Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Novartis Ulcerative Colitis Medicine Product Portfolio Table 62. Novartis Recent Development Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck Ulcerative Colitis Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Merck Ulcerative Colitis Medicine Product Portfolio Table 67. Merck Recent Development Table 68. Sanofi Company Information Table 69. Sanofi Business Overview Table 70. Sanofi Ulcerative Colitis Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Sanofi Ulcerative Colitis Medicine Product Portfolio Table 72. Sanofi Recent Development Table 73. Johnson and Johnson Company Information Table 74. Johnson and Johnson Business Overview Table 75. Johnson and Johnson Ulcerative Colitis Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Johnson and Johnson Ulcerative Colitis Medicine Product Portfolio Table 77. Johnson and Johnson Recent Development Table 78. GSK Company Information Table 79. GSK Business Overview Table 80. GSK Ulcerative Colitis Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. GSK Ulcerative Colitis Medicine Product Portfolio Table 82. GSK Recent Development Table 83. AstraZeneca Company Information Table 84. AstraZeneca Business Overview Table 85. AstraZeneca Ulcerative Colitis Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. AstraZeneca Ulcerative Colitis Medicine Product Portfolio Table 87. AstraZeneca Recent Development Table 88. Cipla Company Information Table 89. Cipla Business Overview Table 90. Cipla Ulcerative Colitis Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Cipla Ulcerative Colitis Medicine Product Portfolio Table 92. Cipla Recent Development Table 93. Sun Pharm Company Information Table 94. Sun Pharm Business Overview Table 95. Sun Pharm Ulcerative Colitis Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Sun Pharm Ulcerative Colitis Medicine Product Portfolio Table 97. Sun Pharm Recent Development Table 98. Allergan Company Information Table 99. Allergan Business Overview Table 100. Allergan Ulcerative Colitis Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Allergan Ulcerative Colitis Medicine Product Portfolio Table 102. Allergan Recent Development Table 103. Teva Pharmaceutical Company Information Table 104. Teva Pharmaceutical Business Overview Table 105. Teva Pharmaceutical Ulcerative Colitis Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Teva Pharmaceutical Ulcerative Colitis Medicine Product Portfolio Table 107. Teva Pharmaceutical Recent Development Table 108. North America Ulcerative Colitis Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Ulcerative Colitis Medicine Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Ulcerative Colitis Medicine Market Share by Country (2021-2026) Table 111. North America Ulcerative Colitis Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Ulcerative Colitis Medicine Market Share Forecast by Country (2027-2032) Table 113. Europe Ulcerative Colitis Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Ulcerative Colitis Medicine Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Ulcerative Colitis Medicine Market Share by Country (2021-2026) Table 116. Europe Ulcerative Colitis Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Ulcerative Colitis Medicine Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Ulcerative Colitis Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Ulcerative Colitis Medicine Market Size by Country (2021-2026) & (US$ Million) Table 120. Asia-Pacific Ulcerative Colitis Medicine Market Share by Country (2021-2026) Table 121. Asia-Pacific Ulcerative Colitis Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Asia-Pacific Ulcerative Colitis Medicine Market Share Forecast by Country (2027-2032) Table 123. Latin America Ulcerative Colitis Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Latin America Ulcerative Colitis Medicine Market Size by Country (2021-2026) & (US$ Million) Table 125. Latin America Ulcerative Colitis Medicine Market Share by Country (2021-2026) Table 126. Latin America Ulcerative Colitis Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Latin America Ulcerative Colitis Medicine Market Share Forecast by Country (2027-2032) Table 128. Middle East & Africa Ulcerative Colitis Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Middle East & Africa Ulcerative Colitis Medicine Market Size by Country (2021-2026) & (US$ Million) Table 130. Middle East & Africa Ulcerative Colitis Medicine Market Share by Country (2021-2026) Table 131. Middle East & Africa Ulcerative Colitis Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Middle East & Africa Ulcerative Colitis Medicine Market Share Forecast by Country (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Ulcerative Colitis Medicine Product Image Figure 3. Global Ulcerative Colitis Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 5. Global Ulcerative Colitis Medicine Market Share by Region: 2025 VS 2032 Figure 6. Global Ulcerative Colitis Medicine Market Share by Region (2021-2032) Figure 7. North America Ulcerative Colitis Medicine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Ulcerative Colitis Medicine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Ulcerative Colitis Medicine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Ulcerative Colitis Medicine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Ulcerative Colitis Medicine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. 5-Aminosalicylic Acid Image Figure 13. Global 5-Aminosalicylic Acid Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Corticosteroids Image Figure 15. Global Corticosteroids Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Immunomodulator Drugs Image Figure 17. Global Immunomodulator Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Biologics Image Figure 19. Global Biologics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Ulcerative Colitis Medicine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Ulcerative Colitis Medicine Market Share by Type 2025 VS 2032 Figure 22. North America Ulcerative Colitis Medicine Market Size Share by Type (2021-2032) Figure 23. Europe Ulcerative Colitis Medicine Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Ulcerative Colitis Medicine Market Size Share by Type (2021-2032) Figure 25. Latin America Ulcerative Colitis Medicine Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Ulcerative Colitis Medicine Market Size Share by Type (2021-2032) Figure 27. Ulcerative Proctitis Image Figure 28. Global Ulcerative Proctitis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Proctosigmoiditis Image Figure 30. Global Proctosigmoiditis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Left-Sided Colitis Image Figure 32. Global Left-Sided Colitis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Pancolitis Image Figure 34. Global Pancolitis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Acute Severe Ulcerative Colitis Image Figure 36. Global Acute Severe Ulcerative Colitis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Global Ulcerative Colitis Medicine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Ulcerative Colitis Medicine Market Share by Application 2025 VS 2032 Figure 39. North America Ulcerative Colitis Medicine Market Size Share by Application (2021-2032) Figure 40. Europe Ulcerative Colitis Medicine Market Size Share by Application (2021-2032) Figure 41. Asia-Pacific Ulcerative Colitis Medicine Market Size Share by Application (2021-2032) Figure 42. Latin America Ulcerative Colitis Medicine Market Size Share by Application (2021-2032) Figure 43. Middle East and Africa Ulcerative Colitis Medicine Market Size Share by Application (2021-2032) Figure 44. Global Top 5 and 10 Ulcerative Colitis Medicine Players Market Share by Revenue in 2025 Figure 45. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 46. North America Ulcerative Colitis Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. North America Ulcerative Colitis Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. North America Ulcerative Colitis Medicine Market Share by Country (2021-2032) Figure 49. Europe Ulcerative Colitis Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Ulcerative Colitis Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Ulcerative Colitis Medicine Market Share by Country (2021-2032) Figure 52. Asia-Pacific Ulcerative Colitis Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Asia-Pacific Ulcerative Colitis Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Asia-Pacific Ulcerative Colitis Medicine Market Share by Country (2021-2032) Figure 55. Latin America Ulcerative Colitis Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Ulcerative Colitis Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Ulcerative Colitis Medicine Market Share by Country (2021-2032) Figure 58. Middle East & Africa Ulcerative Colitis Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Middle East & Africa Ulcerative Colitis Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Middle East & Africa Ulcerative Colitis Medicine Market Share by Country (2021-2032) Figure 61. Years Considered Figure 62. Research Process Figure 63. Key Executives Interviewed

Scope & coverage.

Types
  • 5-Aminosalicylic Acid
  • Corticosteroids
  • Immunomodulator Drugs
  • Biologics
Applications
  • Ulcerative Proctitis
  • Proctosigmoiditis
  • Left-Sided Colitis
  • Pancolitis
  • Acute Severe Ulcerative Colitis
Companies covered
  • Sumitomo
  • Pfizer
  • Novartis
  • Merck
  • Sanofi
  • Johnson and Johnson
  • GSK
  • AstraZeneca
  • Cipla
  • Sun Pharm
  • Allergan
  • Teva Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Ulcerative Colitis Medicine Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Ulcerative Colitis Medicine Market Size by Region (2021-2032)
  5. 1.4.1 Global Ulcerative Colitis Medicine Market Size by Region (2021-2026)
  6. 1.4.2 Global Ulcerative Colitis Medicine Market Size by Region (2027-2032)
  7. 1.5 Key Regions Ulcerative Colitis Medicine Market Size (2021-2032)
  8. 1.5.1 North America Ulcerative Colitis Medicine Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Ulcerative Colitis Medicine Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Ulcerative Colitis Medicine Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Ulcerative Colitis Medicine Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Ulcerative Colitis Medicine Market Size Growth Rate (2021-2032)
2 Ulcerative Colitis Medicine Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 5-Aminosalicylic Acid
  3. 2.1.2 Corticosteroids
  4. 2.1.3 Immunomodulator Drugs
  5. 2.1.4 Biologics
  6. 2.2 Global Ulcerative Colitis Medicine Market Size by Type
  7. 2.2.1 Global Ulcerative Colitis Medicine Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Ulcerative Colitis Medicine Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Ulcerative Colitis Medicine Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Ulcerative Colitis Medicine Market Size by Regions
  11. 2.3.1 North America Ulcerative Colitis Medicine Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Ulcerative Colitis Medicine Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Ulcerative Colitis Medicine Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Ulcerative Colitis Medicine Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Ulcerative Colitis Medicine Market Size Breakdown by Type (2021-2026)
3 Ulcerative Colitis Medicine Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Ulcerative Proctitis
  3. 3.1.2 Proctosigmoiditis
  4. 3.1.3 Left-Sided Colitis
  5. 3.1.4 Pancolitis
  6. 3.1.5 Acute Severe Ulcerative Colitis
  7. 3.2 Global Ulcerative Colitis Medicine Market Size by Application
  8. 3.2.1 Global Ulcerative Colitis Medicine Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Ulcerative Colitis Medicine Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Ulcerative Colitis Medicine Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Ulcerative Colitis Medicine Market Size by Regions
  12. 3.3.1 North America Ulcerative Colitis Medicine Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Ulcerative Colitis Medicine Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Ulcerative Colitis Medicine Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Ulcerative Colitis Medicine Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Ulcerative Colitis Medicine Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Ulcerative Colitis Medicine Industry Trends
  2. 4.2 Ulcerative Colitis Medicine Industry Drivers
  3. 4.3 Ulcerative Colitis Medicine Industry Opportunities and Challenges
  4. 4.4 Ulcerative Colitis Medicine Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Ulcerative Colitis Medicine Revenue (2021-2026)
  2. 5.2 Global Ulcerative Colitis Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Ulcerative Colitis Medicine Key Company Headquarters & Area Served
  4. 5.4 Global Ulcerative Colitis Medicine Company, Product Type & Application
  5. 5.5 Global Ulcerative Colitis Medicine Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Ulcerative Colitis Medicine Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Ulcerative Colitis Medicine Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Ulcerative Colitis Medicine Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Sumitomo
  2. 6.1.1 Sumitomo Company Information
  3. 6.1.2 Sumitomo Business Overview
  4. 6.1.3 Sumitomo Ulcerative Colitis Medicine Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Sumitomo Ulcerative Colitis Medicine Product Portfolio
  6. 6.1.5 Sumitomo Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Ulcerative Colitis Medicine Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Ulcerative Colitis Medicine Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Ulcerative Colitis Medicine Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Ulcerative Colitis Medicine Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Ulcerative Colitis Medicine Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Merck Ulcerative Colitis Medicine Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Sanofi
  26. 6.5.1 Sanofi Company Information
  27. 6.5.2 Sanofi Business Overview
  28. 6.5.3 Sanofi Ulcerative Colitis Medicine Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Sanofi Ulcerative Colitis Medicine Product Portfolio
  30. 6.5.5 Sanofi Recent Developments
  31. 6.6 Johnson and Johnson
  32. 6.6.1 Johnson and Johnson Company Information
  33. 6.6.2 Johnson and Johnson Business Overview
  34. 6.6.3 Johnson and Johnson Ulcerative Colitis Medicine Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Johnson and Johnson Ulcerative Colitis Medicine Product Portfolio
  36. 6.6.5 Johnson and Johnson Recent Developments
  37. 6.7 GSK
  38. 6.7.1 GSK Company Information
  39. 6.7.2 GSK Business Overview
  40. 6.7.3 GSK Ulcerative Colitis Medicine Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 GSK Ulcerative Colitis Medicine Product Portfolio
  42. 6.7.5 GSK Recent Developments
  43. 6.8 AstraZeneca
  44. 6.8.1 AstraZeneca Company Information
  45. 6.8.2 AstraZeneca Business Overview
  46. 6.8.3 AstraZeneca Ulcerative Colitis Medicine Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 AstraZeneca Ulcerative Colitis Medicine Product Portfolio
  48. 6.8.5 AstraZeneca Recent Developments
  49. 6.9 Cipla
  50. 6.9.1 Cipla Company Information
  51. 6.9.2 Cipla Business Overview
  52. 6.9.3 Cipla Ulcerative Colitis Medicine Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Cipla Ulcerative Colitis Medicine Product Portfolio
  54. 6.9.5 Cipla Recent Developments
  55. 6.10 Sun Pharm
  56. 6.10.1 Sun Pharm Company Information
  57. 6.10.2 Sun Pharm Business Overview
  58. 6.10.3 Sun Pharm Ulcerative Colitis Medicine Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Sun Pharm Ulcerative Colitis Medicine Product Portfolio
  60. 6.10.5 Sun Pharm Recent Developments
  61. 6.11 Allergan
  62. 6.11.1 Allergan Company Information
  63. 6.11.2 Allergan Business Overview
  64. 6.11.3 Allergan Ulcerative Colitis Medicine Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Allergan Ulcerative Colitis Medicine Product Portfolio
  66. 6.11.5 Allergan Recent Developments
  67. 6.12 Teva Pharmaceutical
  68. 6.12.1 Teva Pharmaceutical Company Information
  69. 6.12.2 Teva Pharmaceutical Business Overview
  70. 6.12.3 Teva Pharmaceutical Ulcerative Colitis Medicine Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Teva Pharmaceutical Ulcerative Colitis Medicine Product Portfolio
  72. 6.12.5 Teva Pharmaceutical Recent Developments
7 North America
  1. 7.1 North America Ulcerative Colitis Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Ulcerative Colitis Medicine Market Size by Country (2021-2026)
  3. 7.3 North America Ulcerative Colitis Medicine Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Ulcerative Colitis Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Ulcerative Colitis Medicine Market Size by Country (2021-2026)
  3. 8.3 Europe Ulcerative Colitis Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Ulcerative Colitis Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Ulcerative Colitis Medicine Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Ulcerative Colitis Medicine Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Ulcerative Colitis Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Ulcerative Colitis Medicine Market Size by Country (2021-2026)
  3. 10.3 South America Ulcerative Colitis Medicine Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Ulcerative Colitis Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Ulcerative Colitis Medicine Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Ulcerative Colitis Medicine Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst